These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

219 related articles for article (PubMed ID: 23118226)

  • 1. Apolipoproteins and apolipoprotein mimetic peptides modulate phagocyte trafficking through chemotactic activity.
    Madenspacher JH; Azzam KM; Gong W; Gowdy KM; Vitek MP; Laskowitz DT; Remaley AT; Wang JM; Fessler MB
    J Biol Chem; 2012 Dec; 287(52):43730-40. PubMed ID: 23118226
    [TBL] [Abstract][Full Text] [Related]  

  • 2. A subset of five human mitochondrial formyl peptides mimics bacterial peptides and functionally deactivates human neutrophils.
    Kaczmarek E; Hauser CJ; Kwon WY; Riça I; Chen L; Sandler N; Otterbein LE; Campbell Y; Cook CH; Yaffe MB; Marusich MF; Itagaki K
    J Trauma Acute Care Surg; 2018 Nov; 85(5):936-943. PubMed ID: 29787548
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Calpain inhibitors stimulate phagocyte functions via activation of human formyl peptide receptors.
    Fujita H; Kato T; Watanabe N; Takahashi T; Kitagawa S
    Arch Biochem Biophys; 2011 Sep; 513(1):51-60. PubMed ID: 21723247
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Comparison of anti-endotoxin activity of apoE and apoA mimetic derivatives of a model amphipathic peptide 18A.
    Sharifov OF; Nayyar G; Ternovoy VV; Palgunachari MN; Garber DW; Anantharamaiah G; Gupta H
    Innate Immun; 2014 Nov; 20(8):867-80. PubMed ID: 24323453
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Reverse D4F, an apolipoprotein-AI mimetic peptide, inhibits atherosclerosis in ApoE-null mice.
    Qin S; Kamanna VS; Lai JH; Liu T; Ganji SH; Zhang L; Bachovchin WW; Kashyap ML
    J Cardiovasc Pharmacol Ther; 2012 Sep; 17(3):334-43. PubMed ID: 22308547
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Fer kinase limits neutrophil chemotaxis toward end target chemoattractants.
    Khajah M; Andonegui G; Chan R; Craig AW; Greer PA; McCafferty DM
    J Immunol; 2013 Mar; 190(5):2208-16. PubMed ID: 23355730
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Oral D-4F causes formation of pre-beta high-density lipoprotein and improves high-density lipoprotein-mediated cholesterol efflux and reverse cholesterol transport from macrophages in apolipoprotein E-null mice.
    Navab M; Anantharamaiah GM; Reddy ST; Hama S; Hough G; Grijalva VR; Wagner AC; Frank JS; Datta G; Garber D; Fogelman AM
    Circulation; 2004 Jun; 109(25):3215-20. PubMed ID: 15197147
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Apolipoprotein-AI mimetic peptides D-4F and L-5F decrease hepatic inflammation and increase insulin sensitivity in C57BL/6 mice.
    McGrath KC; Li X; Twigg SM; Heather AK
    PLoS One; 2020; 15(1):e0226931. PubMed ID: 31914125
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The anti-infective peptide, innate defense-regulator peptide, stimulates neutrophil chemotaxis via a formyl peptide receptor.
    Lee HY; Bae YS
    Biochem Biophys Res Commun; 2008 May; 369(2):573-8. PubMed ID: 18294454
    [TBL] [Abstract][Full Text] [Related]  

  • 10. A novel method for oral delivery of apolipoprotein mimetic peptides synthesized from all L-amino acids.
    Navab M; Ruchala P; Waring AJ; Lehrer RI; Hama S; Hough G; Palgunachari MN; Anantharamaiah GM; Fogelman AM
    J Lipid Res; 2009 Aug; 50(8):1538-47. PubMed ID: 19225094
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Apolipoprotein E mimetic is more effective than apolipoprotein A-I mimetic in reducing lesion formation in older female apo E null mice.
    Nayyar G; Garber DW; Palgunachari MN; Monroe CE; Keenum TD; Handattu SP; Mishra VK; Anantharamaiah GM
    Atherosclerosis; 2012 Oct; 224(2):326-31. PubMed ID: 22771190
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Fpr2/CXCL1/2 Controls Rapid Neutrophil Infiltration to Inhibit
    Sun Z; Huang W; Zheng Y; Liu P; Yang W; Guo Z; Kong D; Lv Q; Zhou X; Du Z; Jiang H; Jiang Y
    Front Immunol; 2021; 12():786602. PubMed ID: 34899755
    [No Abstract]   [Full Text] [Related]  

  • 13. L-4F inhibits lipopolysaccharide-mediated activation of primary human neutrophils.
    Sharifov OF; Xu X; Gaggar A; Tabengwa EM; White CR; Palgunachari MN; Anantharamaiah GM; Gupta H
    Inflammation; 2014 Oct; 37(5):1401-12. PubMed ID: 24647607
    [TBL] [Abstract][Full Text] [Related]  

  • 14. F2L, a peptide derived from heme-binding protein, inhibits formyl peptide receptor-mediated signaling.
    Lee HY; Lee SY; Shin EH; Kim SD; Kim JM; Lee MS; Ryu SH; Bae YS
    Biochem Biophys Res Commun; 2007 Aug; 359(4):985-90. PubMed ID: 17577578
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Basic characteristics of the neutrophil receptors that recognize formylated peptides, a danger-associated molecular pattern generated by bacteria and mitochondria.
    Dahlgren C; Gabl M; Holdfeldt A; Winther M; Forsman H
    Biochem Pharmacol; 2016 Aug; 114():22-39. PubMed ID: 27131862
    [TBL] [Abstract][Full Text] [Related]  

  • 16. L-4F alters hyperlipidemic (but not healthy) mouse plasma to reduce platelet aggregation.
    Buga GM; Navab M; Imaizumi S; Reddy ST; Yekta B; Hough G; Chanslor S; Anantharamaiah GM; Fogelman AM
    Arterioscler Thromb Vasc Biol; 2010 Feb; 30(2):283-9. PubMed ID: 19965777
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Identification of FAM3D as a new endogenous chemotaxis agonist for the formyl peptide receptors.
    Peng X; Xu E; Liang W; Pei X; Chen D; Zheng D; Zhang Y; Zheng C; Wang P; She S; Zhang Y; Ma J; Mo X; Zhang Y; Ma D; Wang Y
    J Cell Sci; 2016 May; 129(9):1831-42. PubMed ID: 26966188
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Chemotaxis and calcium responses of phagocytes to formyl peptide receptor ligands is differentially regulated by cyclic ADP ribose.
    Partida-Sánchez S; Iribarren P; Moreno-García ME; Gao JL; Murphy PM; Oppenheimer N; Wang JM; Lund FE
    J Immunol; 2004 Feb; 172(3):1896-906. PubMed ID: 14734775
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The FPR2-specific ligand MMK-1 activates the neutrophil NADPH-oxidase, but triggers no unique pathway for opening of plasma membrane calcium channels.
    Karlsson J; Stenfeldt AL; Rabiet MJ; Bylund J; Forsman HF; Dahlgren C
    Cell Calcium; 2009 May; 45(5):431-8. PubMed ID: 19282028
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Potential clinical utility of high-density lipoprotein-mimetic peptides.
    Navab M; Anantharamaiah GM; Reddy ST; Van Lenten BJ; Datta G; Garber D; Fogelman AM
    Curr Opin Lipidol; 2006 Aug; 17(4):440-4. PubMed ID: 16832169
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.